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ABSTRACT
The combination of Eleutherine palmifolia (L.) Merr (EP) and Macrosolen cochinchinensis (Lour.) Tiegh (MC) 
extracts has been proven an empirically potential cure for cancer. The aims of this research were to prove scientifically 
the anticancer potential of the combination of EP and MC as well as its effects on the cell cycle and the apoptosis of 
HeLa cancer cell. The MTT method was used to measure cytotoxic effects. The effect of inhibition of cell cycle and 
induction of cell apoptosis was measured by the flow cytometry method. The results showed that the combination of 
EP and MC gives an induction of apoptosis effect of HeLa cancer cell through inhibition of cell cycle in the G0-G1, 
S, and G2/M phases synergistically until it is synergist strong. Therefore, the combination of EP and MC can be 
recommended as a candidate drug for cancer therapy.
INTRODUCTION
Cervical cancer is a type of cancer that contributes greatly 
to the mortality rate of cancer patients, especially women. This 
type of cancer is the second most common cancer of the women 
with an estimated 445,000 new cases in 2012 or about 84% of new 
cases worldwide (Torre et al., 2015; WHO, 2013). Cervical cancer 
is caused by sexually transmitted infections with the type of HPV 
virus (Human Papilloma Virus).
There are many types of cancer treatment. The most 
common type of cancer treatments is surgery, radiotherapy, and 
chemotherapy but the treatments not obtained optimum results. 
Each of these therapies has some side effects that tend to endanger 
the patient (Arruebo et al., 2011). The frequent failure of cancer 
treatment, mainly through chemotherapy is due to the low 
selectivity of anticancer drugs against normal cells. In addition, the 
failure of chemotherapy is also caused by cancer cell resistance to 
chemotherapeutic agents. The phenomenon of such resistance carry 
consequences on increasing therapeutic dose (Tacar et al., 2013). 
It causes a phenomenon of multi-drug resistance (MDR) that can 
improve therapeutic toxicity (Moitra, 2015).
Therapy using herbal medicine is one solution to the 
phenomenon of the MDR. Previous research has shown that herbal 
medicines derived from natural materials have lower side effects 
than modern medicine (Yuan et al., 2016). Eleutherine palmifolia 
(L.) Merr (EP) is known as Sabrang or Dayak onion. This is a 
traditional medicinal plant from Kalimantan and empirically has 
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been used by the community to treat various diseases, one of them 
is cancer. Some research has shown that the extract is able to 
inhibit cancer growth through inhibition of cell growth cycles and 
induction of the cell apoptosis. It was reported that ethanol and 
ethyl acetate fractions of Sabrang onion were able to inhibit the 
cell cycle of G1-G2 phase by 40.88% (Fitri and Suwarso, 2014). 
It was also reported that the ethanol fraction of Sabrang onion was 
able to suppress the growth of HT29 colon cancer with mutant 
expression of p53 (Yusni et al., 2008).
Not much different from Sabrang onion, Starfruit 
Mistletoe with the scientific name Macrosolen cochinchinensis 
(Lour.) Tiegh (MC) is also a potential anticancer agent. Starfruit 
Mistletoe is a native Indonesian plant that only grows in 
Kalimantan (Febrinda, 2014). Empirical data show that this plant 
for many years has been exploited by the people of Kalimantan as 
a cancer drug. It was reported that Starfruit Mistletoe leaf extract 
is antioxidant as evidenced by DPPH free radical scavenging 
activity (Rahman et al., 2012). This is supported by the results of 
anticancer in vitro test showed that the Starfruit Mistletoe water 
extract of has a strong anticancer activity against T47D breast 
cancer cells by apoptosis induction and cell cycle resistance in 
G0-G1, S, and G2-M (Mutiah et al., 2017).
Based on empirical data, it was known that the 
combination of Sabrang onion (EP) and Starfruit Mistletoe (MC) 
can help to cure cancer patients and has been proven that many 
people were helped by this herb. Therefore, it was important to do a 
scientific proof of the potential of the combination as an anticancer 
drug. The aims of this research were to test the anticancer potential 
of the combination of EP and MC as well as to test its effects on 
the cell cycle and the apoptosis of HeLa cancer cell.
RESEARCH METHODS
Test materials
Plant materials used in this research were Macrosolen 
cochinchinensis (Lour.) Tiegh (MC) and Eleutherine palmifolia 
(L.) Merr (EP) obtained from Malang city of East Java. 
Determination of both plants was done in the Indonesian of 
Sciences Institute (LIPI) in Purwodadi, East Java. Specimen 
number 20170304 and 20170305 were stored in a Laboratory 
of Pharmacognosy, Pharmacy Department, Faculty of Medicine 
and Health Sciences, Maulana Malik Ibrahim State Islamic 
University, Malang.
Materials for extraction
The solvent used for the maceration extraction phase 
was 70% ethanol.
Materials for cell culture
The cancer cell to be used in this research was the 
HeLa cervical line cell. The cells were obtained from the Cancer 
Chemoprevention Research Center (CCRC), Faculty of Pharmacy, 
Gadjah Mada University and from Prof. Masasi Kawaichi, 
Laboratory of Gene Function in Animal, Graduate School of 
Biological Science, Nara Institute of Science and Technology. 
HeLa cells in the Rosewell Park Memorial Institute (RPMI) 
medium was added with 10% of heat-inactivated fetal bovine 
serum (FBS) (PAA Laboratories), 1% v/v penicillin-streptomycin 
(Nacalay Tesque), and 1.0 mM L-glutamine (Nacalay Tesque). 
Then, the cells were cultured in an incubator at 5% CO2 and 95% 
O2 temperature of 37°C.
The cytotoxic test materials
Dimethyl sulfoxide (DMSO) was used to dissolve the 
extracts of EP and MC. The concentration used in this research 
was a maximum of 1% in the culture medium. 0.025% trypsin in 
culture medium was used to harvest cells. Phosphate buffer saline 
(PBS) was used as a buffer solution. 3-(4,5-dimethylthiazole-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) was used as reagents 
that react with the succinate dehydrogenase enzyme in the cell.
Extraction
Eleutherine palmifolia (EP) and Macrosolen 
cochinchinensis (Lour.) Tiegh (MC) were taken from Kalimantan, 
Indonesia. The part of the plant used in the EP is the part of the 
tuber while the MC is the part of the leaf. In each part, sample 
preparation is done by sorting, washing, drying (temperature 
45°C), and pollinated with a smooth degree. Each powder was 
inserted into Erlenmeyer and ethanol 96% solvent was added 
with a ratio of 1:20. Then extracted using ultrasonication assisted 
extraction (UAE) for 2 minutes with three replications. The filtrate 
of C. cinerariifolium leaves from the UAE was evaporated by a 
solvent using rotary evaporator at a temperature of 50°C to produce 
a thick extract. The thick leaf extract is concentrated using an oven 
at 40°C until the extract texture becomes concentrated. Then, the 
yield is calculated by the formula:
×Rendemen = extract weight
simplicia weight
100%
In this research, 200 g of Eleutherine palmifolia (EP) 
powder produces 16.0893 g of extracts so that the EP yield was 
8.04% and 200 g of Macrosolen cochinchinensis (Lour.) Tiegh 
(MC) powder produces 30.46 g of extracts so that the MC yield 
was 15.23%.
Moisture content analysis
In the quality control, the extract used moisture 
content analysis. The extract obtained is then analyzed for water 
content using HC103 halogen moisture analyzer. Samples of 
approximately 0.500 g are inserted into the sample pan, then % 
Moisture Content will appear. In each extract section, Moisture 
Content Analysis is carried out until the water content is less than 
10%. In this study, the moisture content of EP and MC extracts 
was obtained respectively: 5.23% ± 0.25% and 6.45% ± 0.32%.
Test anticancer activity by MTT method
The suspension of HeLa cervical cancer cells, each 
of 100 μl with a density of 3 × 104 cells/100 μl of medium was 
distributed into wells at 96-well plate and incubated for 24 hours. 
After incubation, 100 μl test solution was added into the wells at 
various concentration series. The test solution used was a single 
EP extract. The other test solution was a single MC extract. As 
a cell control, 100 μl culture medium was added into the well 
containing 100 μl cell suspension and as a solvent control 100 μl 
DMSO was added into the well containing 100 μl culture medium 
and 100 μl cell suspension with delusions corresponding to the 
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delusions of the test solution concentration, and then incubated 
for 24 hours in incubator with 5% CO2 and 95% O2 flow. At the 
end of incubation, the culture medium was removed and 10 μl of 
MTT solution (5 mg/ml PBS) was added, and the medium was 
replaced with 190 μl of complete RPMI 1640 medium. Then, cells 
were incubated for 3–4 hours. The MTT reaction was discontinued 
the addition of an SDS stopper reagent (100 μl). The microplate 
was then wrapped in a tissue and incubated for a night at room 
temperature and dark room. Living cells react with MTT to form a 
purple color. Test results were read with ELISA reader at 595 nm 
wavelength (Mutiah, 2014). The test results of single therapy of 
Starfruit Mistletoe extract and Sabrang onion extract on HeLa 
cancer cells with MTT method is presented in Table 1.
Analysis of cell cycle with flow cytometry
In this cell cycle analysis used Propidium Iodide dye 
(PI). This dye can be used to analyze the number of DNA sets in 
each cell. Cells of 5 × 105 cells/wells were planted in a 6-well plate 
and then incubated until normal again. Cells were treated with 
DMSO solvent (0.25%) and active isolates on IC50. The cells were 
then reincubated for 24 hours. At the end of the incubation time, 
the medium was taken and transferred into a tube and centrifuged 
(2,000 rpm, 3 minutes) and then, the supernatant was removed. At 
the well that has been taken it medium, PBS was added and PBS 
were transferred to the same microtube from one treatment, then 
centrifuged and the supernatant was discarded. This stage was 
repeated once more and the cells were harvested with trypsin. Cells 
were transferred into the same microtube and then centrifuged 
(2,000 rpm, 3 minutes). The rest of the harvesting cells that are 
on the well were rinsed with PBS and centrifuged again, then the 
PBS was discarded. The cell sediments in the microtube were 
then fixed with 70% ethanol, −20°C, incubated for 30 minutes at 
room temperature or overnight at 4°C, then centrifuged (371 g; 
3 minutes). The cell sediment was washed with PBS twice and 
then was added with PI reagents with caution, and immediately 
homogenized. The microtube containing the cell suspension was 
wrapped in aluminum foil and incubated in a 37°C water bath 
for 20 minutes. The cell suspension was homogenized again and 
transferred into a flow cytometer tube using a nylon filter, then 
ready to be analyzed with a flow cytometer (Mutiah et al., 2018b).
Analysis of induced apoptosis cell with flow cytometry
Cells of 5 × 105 cells/wells were planted in a 6-well 
plate, and then the cells were incubated until normal again. Cells 
were treated with DMSO solvent (0.25%) and active isolates. 
The cells were then reincubated for 24 hours. At the end of the 
incubation time, the medium was taken and transferred into a tube 
and centrifuged (371 g; 3 minutes) and then the supernatant was 
removed. At the well that has been taken it medium, PBS was added 
and PBS was transferred to the same microtube from one treatment, 
then centrifuged and then the supernatant layer was removed. This 
stage was repeated once more and the cells were harvested with 
trypsin. Cells were transferred into the same microtube and then 
centrifuged (371 g; 3 minutes). The rest of the harvesting cells that 
were on the well were rinsed with PBS and centrifuged again, and 
then the PBS was discarded. The sediment was added with PI-
Annexin V reagents with caution and immediately homogenized. 
The microtube containing the cell suspension was wrapped in 
aluminum foil and incubated in a 37°C of water bath for 5 minutes. 
The cell suspension was homogenized again and transferred into 
a flow cytometer tube using a nylon filter, and then ready to be 
analyzed with a flow cytometer (Mutiah et al., 2018b).
Data analysis
The data obtained in form of absorbance of each well 
converted into living cell percentage:
−
−
×
( )
( )Percentage (%) of living cell =
treatment abs. media control abs.
cell control abs. media control abs.
100%
Description: Abs: absorbance
Percentage of living cells was calculated to obtain an 
IC50 value that is the concentration causing inhibition of growth as 
much as 50% of the cell population so that the cytotoxic potential 
can be known. The value of IC50 was determined by probit analysis 
[Statistic Product and Service Solution (SPSS) 16.0 for Windows].
Combined cytotoxicity was determined by calculating 
the interaction index between the extract of Starfruit Mistletoe 
(MC) and the Sabrang Onion Extract (EP), using the equation:
Combination Index/CI = (D) 1/(Dx) 1 + (D) 2/(Dx) 2
D1 and D2 were the sample concentrations used in the 
combination treatment. (Dx) 1 and (Dx) 2 were single concentrations 
which can produce the effect, as big as given by the combined 
treatment (Reynold and Maurer, 2005). The resulting CI or 
Combination Index obtained was interpreted as follows: <0.1 very 
strong synergistic effect, 0.1–0.3 strong synergistic effect, 0.3–0.7 
synergistic effect, 0.7–0.9 mild-moderate synergistic effect, 0.9–1.1 
close to the additive effect, 1.1–1.45 mild-moderate antagonist effect, 
1.45–3.3 antagonistic effect, > 3.3 strong-very strong antagonistic 
effect (Mutiah et al., 2018a).
RESULTS AND DISCUSSION
Effect of E. palmifolia and M. cochinchinensis combination on 
HeLa cancer cells
The aims of this research were to explain the effect of 
giving combination Sabrang onion (EP) and starfruit mistletoe 
(MC) extracts on anticancer activity, cell cycle, and HeLa cervical 
cancer cell-induced apoptosis. The anticancer potential of EP 
and MC combination on HeLa cancer cells was known through 
MTT test (3-4,5-dimethilthiazole-2-il)-2,5-diphenyltetrazolium). 
Table 1. The average of cell viability percentage and IC50 crude of EP and MC extracts value on HeLa cancer cells.
No Extract
Average% Hela cell viability ± SD * at test concentration (μg/ml)
IC50 (μg/ml) ± SD*7.813 15625 31.25 62.5 125 250 500
1 MC 99.09 ± 0.45 99.54 ± 0.89 94.53 ± 0.78 85.09 ± 1.25 85.41 ± 2.45 38.22 ± 0.69 18.76 ± 0.55 217.72 ± 0.034
2 EP 66.41 ± 0.56 77.05 ± 0.64 56.38 ± 0.32 56.00 ± 0.98 32.59 ± 0.43 7.45 ± 0.76 6.91 ± 1.56 40.36 ± 0.05
*Mean value and deviation with three replications
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The combined dosage used was 16 doses under IC50. The results of 
the effectiveness test of EP and MC combination on HeLa cancer 
cells were compared with single therapy, so it can be known the 
efficacy of the combination preparation compared to the single 
preparation. Previously, we needed to test the cytotoxic activity 
of single preparation to determine IC50. The result of a single 
cytotoxic test of EP and MC has been written in Table 1.
Once the IC50 of each extract is known, the test on the 
combination of both extracts on HeLa cancer cells is performed. 
The combination test was performed with each of 16 concentrations 
series below the concentration of IC50. The purpose of the dosage 
used under IC50 is to obtain a dose combination which has a high 
anticancer effect on low doses so it is expected to reduce side 
effects and decrease toxicity on normal cells.
Of the 16 combinations tested showed that the 
combination of EP and MC gave a very strong synergistic effect 
until the antagonist was very strong against the inhibition of 
growth of HeLa cells (Table 3). The combination of doses having 
a strong synergistic effect was the dose of EP 22.62 μg/ml and MC 
23.3 μg/ml with Combination Index of 0.15. The combination of 
doses that have the synergistic effect was a combination of doses 
of 23.3 μg/ml MC and 11.31 µg/ml EP; 23.3 ug/ml MC and 16.96 
ug/ml EP. The dosage may be recommended for further research. 
The test result of the MTT method of EP and MC combination 
was presented in Tables 2 and 3. The graph of the combination 
isobologram was shown in Figure 1 below:
104 cells/wells were planted on well plates, incubated 
for 24 hours in RPMI medium without or with the combination 
treatment of EP and MC with a predetermined concentration. Cell 
viability was determined by the MTT method. The results of this 
analysis were the representations of two different experiments, 
each with three replications.
Table 2. HeLa cell viability percentage due to the treatment of EP and MC extracts combination.
EP (µg/ml)
*Cell viability%
MC 
(23.3 µg/ml)
MC 
(46.6 µg/ml)
MC 
(69.9 µg/ml)
MC 
(93.28 µg/ml)
5.65 71.43 ± 9.86 82.77 ± 0.52 77.56 ± 1.66 63.6 ± 2.03
11.31 67.036 ± 9.57 81.75 ± 2.4 75.29 ± 1.48 60.18 ± 2.79
16.96 68.14 ± 10.6 78.57 ± 1.89 73.89 ± 3.01 79.34 ± 2.4
22.62 56.37 ± 6.35 75.00 ± 4.27 74.08 ± 4.27 78.9 ± 2.21
*Average ± Standard Deviation, n = 3
Table 3. Analysis of synergism effect on the treatment of EP and MC extracts combination on HeLa Cell Line.
EP (µg/ml)
Combination index
MC
(23.3 µg/ml)
MC
(46.6 µg/ml)
MC
(69.9 µg/ml)
MC
(93.28 µg/ml)
5.65 0.81 6.39 4.91 1.13
11.31 0.51 6.07 3.86 0.75
16.96 0.64 4.31 3.36 8.70
22.62 0.15 2.87 3.58 8.52
MC: Extract of Macrosolen cochinchinensis (Lour.) Tiegh
EP: Extract of Eleutherine palmifolia (L.) Merr
Figure 1. The effect of the combination of E.palmifolia (EP) and M. cochinchinensis (MC) treatment on the growth of HeLa cervical cancer cells. 
(A) The effect of combination treatment on cell viability. (B) Combination Index (CI) from a combination of EP and MC.
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Analysis Results of HeLa cell cycle regulation due to the 
treatment of EP and MC combination
Observation of the HeLa cell cycle due to of the 
combination treatment of EP and MC. This aims to determine 
whether the combination of EP and MC can direct the HeLa 
cancer cell cycle to the checkpoint phase. Checkpoint 
control plays a role in regulating abnormalities at every 
stage of the cycle cell, which serves to prevent the cells 
from entering the next stage in the case of DNA damage. 
In cancer cells, the inability of checkpoint control occurs in 
the cell cycle stage so that discontinued DNA replication to 
mitosis despite DNA damage. This causes the cancer cells to 
proliferate uncontrollably (Worthley et al., 2007).
Analysis of cell cycle was done by fluorescence-activated 
cell sorting method using Propidium Iodine (PI) probe. Figure 3 
shows that the combination treatments of EP and MC at IC50 doses 
can inhibit regulation of cell cycle marked by the increasing 
accumulation of cell in a G2-M phase of 17.66% and a synthesis 
of 28.35% following depletion of G0-G1 phase accumulation 
compared to control cells. The M1–M5 cycle shows the number of 
dead cells. The treatment of the number of dead cells combination 
shows the increase of 18.47% (Fig. 3). The statistical test results 
indicate that the depletion of G0-G1 phase accumulation differs 
significantly to control (p < 0.001). The result of the cell cycle 
regulation test is presented in Figure 2.
Analysis of HeLa Cell Apoptosis Induction on the Treatment of 
EP and MC Combination
Observation of apoptosis induction was performed to 
determine the cause of cell death both in apoptosis, and necrosis. 
Flow cytometry method is able to distinguish living cells, early 
Figure 2. Effects of induction of cell death and changes in distribution in the cell cycle phase of cancer cells HeLa cervical treatment (A) Control 
with DMSO solvent (B) Combination EP and MC at the dosage of IC50. HeLa cells as much as 5 × 10
5 cells/well, incubated for 24 hours and given 
a combination treatment on IC50. The profile distribution of each phase (G1, M, S, and G2/M) in the cell cycle was analyzed using flow cytometry 
with Propidium Iodide (PI) painting.
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apoptosis, late apoptosis and necrosis because the Annexin V and PI 
reagents work selectively in binding the intact or fragmented cells.
The treatment of EP and MC combination on HeLa 
cervical cancer cells causes cells to increase apoptosis 9.19% 
compared to control treatment (DMSO) (Fig. 3). Based on statistical 
test results it showed that the increase of apoptosis induction was 
significantly different with control (p < 0.001). Increased apoptosis 
of these cells is in line with increasing cell accumulation in the G0 
phase. The result of apoptosis induction test using flow cytometry 
is presented in Figure 3 below:
Flavonoid and polyphenol compounds have been studied 
for their effectiveness as chemoprevention agents that have a variety 
of activities and functional targets either as blocking, suppressing, 
or anti-metastatic/anti-invasive cancer cells. Eleutherine palmifolia 
(L.) Merr (EP) contains flavonoid isoliquiritigenin compounds. 
These compounds have been shown to have chemoprevention effects 
through apoptosis induction and are able to inhibit metastases cancer 
cell through inhibition of neoangiogenesis in VEGF/VEGFR-2 
Signaling Pathway (Wang et al., 2013). Several previous studies 
have shown that isoliquiritigenin compounds have chemoprevention 
activity on B16 melanoma cells (Iwasitha et al., 2000), colon cancer 
cells (Takashi et al, 2004), breast cancer cells (Wang, et al., 2013), 
and squamous cell (Hou et al., 2017). Another flavonoid compound 
also found in Dayak onion bulbs was oxyresveratrol compounds.
Macrosolen cochinchinensis (Lour.) Tiegh (MC) contains 
flavonoids, especially quercetin. These compounds were known to 
play the role of capturing free radicals or functioning as a natural 
antioxidant. Such antioxidant activity allows flavonoids to capture 
or neutralize free radicals (such as ROS or RNS which are one of 
the causes of oncogenesis) associated with phenolic OH groups. 
Flavonoids in mango mistletoe, quercetin, which was a compound that 
can be used as an anticancer also have the ability as anti-proliferation. 
Quercetin may act as an anticancer to cell cycle regulation because it 
can suppress p53 protein mutant expression in cell cycle control by 
stimulating an arrested or apoptotic cell so there is no excessive cell 
proliferation (Gibellini et al., 2011). Quercetin is also a compound 
that can inhibit neutrophil migration since quercetin may inhibit 
the COX-2 enzyme. COX-2 enzyme mediates arachidonic acid 
conversion into prostaglandin and leukotriene which is a chemical 
mediator of neutrophil migration (Xiao et al., 2011).
Figure 3. Shows the results of cell distribution and analysis of cell death induction/cell quest using Flow cytometry method (A) HeLa cells control method, (B) 
Treatment of EP and MC combination on HeLa cells, and (C) Comparison graph of viable, apoptosis and necrosis cell.
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CONCLUSION
Combination of Eleutherine palmifolia (L.) Merr (EP) 
and Macrosolen cochinchinensis (Lour.) Tiegh (MC) extracts has 
a strong synergistic effect on the EP 22.62 μg/ml and MC 23.3 
ug/ml doses with a combination index of 0.15. The combination 
of doses giving synergistic effect was a combination of MC 23.3 
μg/ml and EP 11.31 dose; MC 23.3 μg/ml and EP 16.96 μg/ml 
dose. Combination of EP and MC extracts affects the cell cycle 
inhibition in G0-G1, G2/M, and S (synthesis) phase. It can also 
increase the apoptosis of HeLa cancer cell.
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